What is Sino-American Pharmaceutical's stock code?

Sino-American Pharmaceutical's stock code is 1734.

What industry does Sino-American Pharmaceutical belong to?

Sino-American Pharmaceutical belongs to the biotechnology and healthcare industry.

What were Sino-American Pharmaceutical's Q4 2025 earnings per share?

Sino-American Pharmaceutical's Q4 2025 basic earnings per share (EPS) were NT$1.92.

What was Sino-American Pharmaceutical's revenue in Q4 2025?

Sino-American Pharmaceutical's revenue in Q4 2025 was NT$3.371 billion.

What was Sino-American Pharmaceutical's net profit after tax in Q4 2025?

Sino-American Pharmaceutical's net profit after tax in Q4 2025 was NT$354 million.

AI News NQ Analysis

Sino-American Pharmaceutical Co., Ltd. Q4 2025 EPS NT$1.92

NQ Score 53/100

N1 Content Completeness 3

AI Summary (NQ-processed)

Sino-American Pharmaceutical Co., Ltd. (1734) reported its Q4 2025 financial results, with basic earnings per share (EPS) at NT$1.92. The company's revenue was NT$3.371 billion, and net profit after tax was NT$354 million.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is Sino-American Pharmaceutical's stock code?: A: Sino-American Pharmaceutical's stock code is 1734.
Q: What industry does Sino-American Pharmaceutical belong to?: A: Sino-American Pharmaceutical belongs to the biotechnology and healthcare industry.
Q: What were Sino-American Pharmaceutical's Q4 2025 earnings per share?: A: Sino-American Pharmaceutical's Q4 2025 basic earnings per share (EPS) were NT$1.92.
Q: What was Sino-American Pharmaceutical's revenue in Q4 2025?: A: Sino-American Pharmaceutical's revenue in Q4 2025 was NT$3.371 billion.
Q: What was Sino-American Pharmaceutical's net profit after tax in Q4 2025?: A: Sino-American Pharmaceutical's net profit after tax in Q4 2025 was NT$354 million.